AXXE Stock UPDATES Axxess Pharma Inc. (AXXE) 0.1970 09/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Axxess Pharma Inc. (AXXE) 0.1970 $AXXE

Axxess Pharma Inc. Signs UFC Welterweight Fighter Tyron Woodley as Spokesperson
Marketwire - Tue Sep 02, 7:03AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., Tyron Woodley, UFC Welterweight fighter will be joining Axxess Pharma as spokesperson.

Axxess Pharma to Market Latest All-Natural TapouT Products to Over 50,000 US Military Personnel at Fort Hood, Texas on November 1, 2014
Marketwire - Wed Aug 27, 7:01AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc., that they will be marketing their latest all-natural TapouT products to over 50,000 US military personnel at Fort Hood, Texas on Saturday, November 1st, 2014. This comes at a time when the US military (AAFES) continues to increase orders of TapouT products on a monthly basis.

Axxess Pharma Inc. Announces US Military (AAFES) Re-Ordering TapouT Product Line at Accelerated Rate
Marketwire - Thu Aug 21, 7:00AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc., that the US military (AAFES) is continuing to reorder their high demand TapouT product line at an accelerated rate.

Axxess Pharma Reports Increased Global Sales Fueled by Aggressive Social Media Marketing, Additional Distributor Relationships and Celebrity Athlete Sponsorships
Marketwire - Tue Aug 19, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce sales is continuing to accelerate in the United States, Canada and Australia. Management is now preparing to expand global sales into New Zealand, South Korea and Indonesia.

Axxess Pharma has a Portfolio of Products to Market; Analyst Report by SmallCapIR and Issued by BrokerBank Securities, Inc.
PR Newswire - Wed Aug 13, 1:00PM CDT
Axxess Pharma, Inc. (OTCBB: AXXE) offers products targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability.

Axxess Pharma, Inc. Targets Celebrity Athlete Fan Base and Retail Customer Base Through Aggressive, Targeted Online Social Media Campaign
Marketwire - Tue Aug 12, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc., that they have signed SA Studios Global, an integrated marketing and branding firm, to assist Axxess Pharma in its online and offline marketing initiatives. SA Studios Global has vast experience managing and maximizing brand social media for companies.

Axxess Pharma Announces TapouT Product Line Now Approved by Australian Regulatory Authority: TGA
Marketwire - Tue Aug 05, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that Hard Core Beverage, its distributor for the Australia region has received approval from the Australia The Australian Regulatory Authority (TGA), to sell all of the TapouT product line in Australia. Australia is generally considered to be one of the most stringent jurisdictions for nutritional supplements and natural health products.

Axxess Pharma Inc. Secures $2 Million USD in Financing to Fulfill Increased Rate of Purchase Orders
Marketwire - Wed Jul 30, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc., that they have secured $2,000,000 USD in financing. Funds will be used to fulfill current purchase orders and increase marketing and inventory of products. Management will also quickly add new high-demand products that have been requested by buyers to round out the TapouT Muscle Growth and Recovery line.

Axxess Pharma Announces Audited Financials and S-1 Registration Statement Now Filed With SEC for Up-Listing to Over The Counter Bulletin Board (OTC: BB) Stock Exchange
Marketwire - Mon Jul 28, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that it has completed their audited financials and have now filed their S-1 registration statement to become a fully reporting company on the more liquid Over The Counter Bulletin Board (OTC: BB) stock exchange. This listing will allow investors, stock brokers, wealth managers and Portfolio Managers to have improved tradability of the stock (PINKSHEETS: AXXE).

Axxess Pharma and AllStar Health Brands to Meet Additional Distributors at World Renowned 2014 Olympia's Fitness & Performance Expo
Marketwire - Wed Jul 23, 7:03AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce that its wholly-owned subsidiary, AllStar Health Brands Inc., will be presenting their all-natural TapouT product line at the world renowned 2014 Olympia's Fitness and Performance Expo. The expo will be help September 19th thru 20th at the Las Vegas Convention Center - South Halls 1 & 2.

Axxess Pharma Announces Financial Audits and Form S-1 to Be Filed With SEC Within One Week for Fully Reporting Status
Marketwire - Thu Jul 17, 7:01AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that it has completed their PCAOB audited financial statements.

Axxess Pharma Inc. Announces US Military (AAFES) Quickly Increasing Rate of Purchase Orders for TapouT Line of Products
Marketwire - Wed Jul 16, 7:00AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly owned subsidiary AllStar Health Brands Inc. that they have received their third purchase order from the Army Air Force Exchange Service (AAFES). This is the second purchase order from AAFES within 2 weeks. The latest purchase order is for TapouT's line of all-natural pain relief products. The first purchase order by AAFES was valued at almost $30,000.

Axxess Pharma Becomes Primary Sponsor for Cole Whitt at New Hampshire Motor Speedway and Phoenix International Raceway
Marketwire - Thu Jul 10, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that it has partnered with BK Racing and Sunoco Rookie of the Year Contender Cole Whitt.

Revive Bioscience Retracts Press Release of Jun 24, 2014
GlobeNewswire - Tue Jul 08, 12:04PM CDT
Revive Bioscience states that it will not rescind the Axxess Pharma Inc. Asset Purchase Agreement, following the successful resolution of certain undisclosed and outstanding items. Revive recognizes Axxess Pharma Inc. ownership of the TapouT license, products and related patents. Axxess Pharma Inc. has achieved remarkable strides in the marketing of existing products and the development of a new product line. We clearly see the long-term potential and benefits of our current alliance with Axxess Pharma Inc., and support all of their efforts.

Axxess Pharma Announces Strong Interest From International Distributors at the UFC Fan Expo(R) Event
Marketwire - Tue Jul 08, 7:02AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that its wholly-owned subsidiary, AllStar Health Brands Inc., has received strong interest from international distributors and fans at the UFC Fan Expo(R) held this past weekend in Las Vegas.

Axxess Pharma Inc. Receives Additional Purchase Order From US Military (AAFES) for TapouT Line of Products
Marketwire - Tue Jul 01, 11:53AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary AllStar Health Brands Inc. that it has received an additional purchase order from the Army Air Force Exchange Service (AAFES). The prior purchase order was valued at almost $30,000.

Axxess Pharma Reports VP of Business Development of ABG TapouT Reiterates AXXE Is Legal Licensee of TapouT Brand
Marketwire - Thu Jun 26, 6:01AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., today has reaffirmed they hold legal licensee rights for the TapouT brand as it pertains to Pain Relief, Supplements, Vitamins and Minerals.

Revive BioScience Ltd. Rescinds Asset Purchase Deal with Axxess Pharma Inc.
GlobeNewswire - Tue Jun 24, 5:48PM CDT
Revive BioScience Ltd. has rescinded the asset purchase agreement for the company's TapOut brand of products and related patents with Axxess Pharma Inc. for (OTC Pink:AXXE) for failure to complete the transaction. As part of the rescission Revive is demanding that all its assets to be returned to Revive by Axxess. Revive will further be looking to recover damages from Axxess based on the many misrepresentations Axxess has made in the market place about its assets when the asset purchase was never properly completed.

Axxess Pharma to Launch High Protein, Fat Burning Ready to Drink (RTD) Protein Meal Replacement Products in Fall of 2014
Marketwire - Tue Jun 24, 6:00AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that they will be launching a line high protein, fat burning Ready to Drink (RTD), protein meal replacement products in the fall of 2014. The early launch of these products was fueled by the strong feedback from several large, national US retailers.

Axxess Pharma Becomes Primary Sponsor of NASCAR Sprint Cup Driver Cole Whitt
Marketwire - Thu Jun 19, 6:01AM CDT
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that it has partnered with BK Racing, LLC, Cole Whitt Racing, LLC and Wide-Open Sports Marketing, Inc. Axxess Pharma will serve as primary sponsor of the No. 26 BK Racing NASCAR Sprint Cup Series ("NSCS" Toyota Camry. AllStar Health Brands high demand TapouT Muscle Recovery product will be fully branded on the Hood, Upper Rear Quarter Panels, TV Panel and below Roof Number.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading